1. Home
  2. INSG vs TLSA Comparison

INSG vs TLSA Comparison

Compare INSG & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inseego Corp.

INSG

Inseego Corp.

HOLD

Current Price

$11.40

Market Cap

174.9M

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.62

Market Cap

182.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSG
TLSA
Founded
1996
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
174.9M
182.7M
IPO Year
2000
2000

Fundamental Metrics

Financial Performance
Metric
INSG
TLSA
Price
$11.40
$1.62
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$15.33
N/A
AVG Volume (30 Days)
167.7K
310.3K
Earning Date
02-19-2026
05-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$165,876,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$14.34
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.24
$0.63
52 Week High
$18.11
$2.60

Technical Indicators

Market Signals
Indicator
INSG
TLSA
Relative Strength Index (RSI) 52.73 52.75
Support Level $11.49 $1.36
Resistance Level $12.71 $1.75
Average True Range (ATR) 0.68 0.13
MACD 0.19 0.03
Stochastic Oscillator 55.38 69.77

Price Performance

Historical Comparison
INSG
TLSA

About INSG Inseego Corp.

Inseego Corp is into the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware. It generates maximum revenue from United States and Canada. The company also has a presence in Australia and Europe (including United Kingdom).

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: